GlassScriptPhysician profile
Whitney Bowling
NPI 1891058731
$1,552.44
in general payments reported to CMS, 2019-2025
17 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $314 · 2022: $265 · 2023: $394 · 2024: $440 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $394.30 | 2021-2024 | Jardiance, Synjardy |
| Astrazeneca Pharmaceuticals LP | $318.50 | 2021-2025 | Farxiga, Breztri |
| Amgen INC. | $312.45 | 2023-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $202.47 | 2021-2024 | Mounjaro, Zepbound |
| Pfizer INC. | $90.70 | 2024 | |
| Insulet Corporation | $32.00 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $31.20 | 2022 | |
| Cequr Corporation | $22.60 | 2025 | Cequr Simplicity |
| Biogen, INC. | $22.09 | 2024 | Skyclarys |
| Ultragenyx Pharmaceutical INC. | $20.05 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $17.77 | 2021 | |
| Novo Nordisk INC | $17.33 | 2023 | |
| Abbvie INC. | $15.57 | 2024 | |
| Exact Sciences Corporation | $14.28 | 2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $14.07 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $13.85 | 2023 | |
| Paratek Pharmaceuticals, INC. | $13.21 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Bowling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.